Covid-19: Metformin reduces the risk of developing long term symptoms by 40%, study finds

BMJ. 2023 Jun 8:381:1306. doi: 10.1136/bmj.p1306.
No abstract available

MeSH terms

  • COVID-19*
  • Diabetes Mellitus, Type 2*
  • Humans
  • Hypoglycemic Agents / adverse effects
  • Metformin* / therapeutic use

Substances

  • Metformin
  • Hypoglycemic Agents